These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 29996118

  • 1. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
    Dong X, Chen G, Cai Z, Li Z, Qiu L, Xu H, Yuan Y, Liu XL, Liu J.
    Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
    [Abstract] [Full Text] [Related]

  • 2. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
    Ramírez-Moya J, Miliotis C, Baker AR, Gregory RI, Slack FJ, Santisteban P.
    Mol Cancer; 2021 Sep 08; 20(1):115. PubMed ID: 34496885
    [Abstract] [Full Text] [Related]

  • 3. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, Yuan YF, Tenen DG, Guan XY, Chen L.
    Gut; 2014 May 08; 63(5):832-43. PubMed ID: 23766440
    [Abstract] [Full Text] [Related]

  • 4. ARID1A loss promotes RNA editing of CDK13 in an ADAR1-dependent manner.
    Zhu T, Li Q, Zhang Z, Shi J, Li Y, Zhang F, Li L, Song X, Shen J, Jia R.
    BMC Biol; 2024 Jun 05; 22(1):132. PubMed ID: 38835016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
    Wang J, Zhang Y, Lu L, Lu Y, Tang Q, Pu J.
    J Cell Biochem; 2019 Nov 05; 120(11):18816-18825. PubMed ID: 31297882
    [Abstract] [Full Text] [Related]

  • 7. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y, Toiyama Y, Shigeyasu K, Yamamoto A, Shigemori T, Yin C, Ichikawa T, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Araki T, Kusunoki M, Goel A.
    J Transl Med; 2018 Dec 18; 16(1):366. PubMed ID: 30563560
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ, Jung J, Jiang L, Lee EJ, Kim DS, Kim BS, Kim HS, Jung HY, Song HJ, Hwang SW, Park Y, Jung MK, Pack CG, Myung SJ, Chang S.
    Dig Dis Sci; 2018 Jul 18; 63(7):1835-1850. PubMed ID: 29691780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF, Liu H, Fei J, Li Y, Guan XY, Chen L.
    Cancer Res; 2014 Feb 01; 74(3):840-51. PubMed ID: 24302582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S, Galipon J, Ishii R, Suzuki Y, Kondo S, Okada-Hatakeyama M, Tomita M, Ui-Tei K.
    RNA Biol; 2018 Feb 01; 15(7):976-989. PubMed ID: 29950133
    [Abstract] [Full Text] [Related]

  • 17. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
    Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, Lin JS, Ng VH, Song Y, Hong H, Tay ST, Liu Y, Lee J, Rha SY, Zhu F, So JB, Teh BT, Yeoh KG, Rozen S, Tenen DG, Tan P, Chen L.
    Gastroenterology; 2016 Oct 01; 151(4):637-650.e10. PubMed ID: 27373511
    [Abstract] [Full Text] [Related]

  • 18. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X, Fu Y, Huang J, Wu M, Zhang Z, Xu R, Zhang P, Zhao S, Liu L, Jiang H.
    J Exp Clin Cancer Res; 2019 Jul 17; 38(1):315. PubMed ID: 31315644
    [Abstract] [Full Text] [Related]

  • 19. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
    Nakano M, Fukami T, Nakajima M.
    J Pharmacol Exp Ther; 2019 Sep 17; 370(3):408-415. PubMed ID: 31270214
    [Abstract] [Full Text] [Related]

  • 20. RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.
    Li Y, Wang NX, Yin C, Jiang SS, Li JC, Yang SY.
    Int J Mol Sci; 2022 Aug 25; 23(17):. PubMed ID: 36077054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.